Globus Medical (GMED) Tops Q4 EPS by 10c; offers guidance

Globus Medical (NYSE: GMED) reported Q4 EPS of $0.84, $0.10 better than the analyst estimate of $0.74. Revenue for the quarter came in at $657.29 million versus the consensus estimate of $635.43 million.

GUIDANCE:

Globus Medical sees FY2025 EPS of $3.10-$3.40, versus the consensus of $3.43. Globus Medical sees FY2025 revenue of $2.8-2.9 billion, versus the consensus of $2.672 billion.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)
• NVIDIA (NVDA) call put ratio 1.9 calls to 1 put with a focus on 5K contracts of October 160 puts